Literature DB >> 2875948

Interaction of a 60-kilodalton D-mannose-containing salivary glycoprotein with type 1 fimbriae of Escherichia coli.

J P Babu, S N Abraham, M K Dabbous, E H Beachey.   

Abstract

A 60-kilodalton glycoprotein previously isolated and purified from human saliva (J. B. Babu, E. H. Beachey, D. L. Hasty, and W. A. Simpson, Infect. Immun. 51: 405-413, 1986) was found to interact with type 1 fimbriae and prevent adhesion of type 1 fimbriated Escherichia coli to animal cells in a D-mannose-sensitive manner. Purified salivary glycoprotein agglutinated type 1 fimbriated E. coli and, at subagglutinating concentrations, blocked the ability of type 1 fimbriated E. coli to attach to human buccal epithelial cells or agglutinate guinea pig erythrocytes. Both interactions were inhibited by alpha-methyl-D-mannoside but not by alpha-methyl-D-glucoside. Complexing of the glycoprotein to type 1 fimbriae was demonstrated by molecular sieve chromatography and modified Western blots. When mixed with type 1 fimbriae, the radiolabeled salivary glycoprotein coeluted with type 1 fimbriae from a column of Sepharose 4B. When blotted from a sodium dodecyl sulfate gel to nitrocellulose sheets, the glycoprotein interacted directly with type 1 fimbriae applied to the blots. Both of the latter interactions also were blocked by alpha-methyl-D-mannoside but not by alpha-methyl-D-glucoside. Chemical modification of the glycoprotein with sodium metaperiodate abolished its ability to interact with isolated type 1 fimbriae or type 1 fimbriated E. coli. These results suggest that the carbohydrate moiety of the 60-kilodalton glycoprotein serves as a receptor for type 1 fimbriae in the oral cavity, and we postulate that the interaction may cause agglutination and early removal of E. coli, thereby preventing colonization by these organisms of oropharyngeal mucosae and dental tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875948      PMCID: PMC260123          DOI: 10.1128/iai.54.1.104-108.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The isolation and partial characterization of a sulphated glycoprotein from human whole saliva which aggregates strains of Streptococcus sanguis but not Streptococcus mutans.

Authors:  S D Hogg; G Embery
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Proline-rich proteins from human parotid saliva. I. Isolation and partial characterization.

Authors:  F G Oppenheim; D I Hay; C Franzblau
Journal:  Biochemistry       Date:  1971-11       Impact factor: 3.162

4.  Isolation, purification and chemical characterization of mucins from human submandibular glands.

Authors:  I Oemrawsingh; P A Roukema
Journal:  Arch Oral Biol       Date:  1974-08       Impact factor: 2.633

5.  Partial characterization of five glycoprotein fractions secreted by the human parotid glands.

Authors:  P Arneberg
Journal:  Arch Oral Biol       Date:  1974-10       Impact factor: 2.633

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Characteristics of some high molecular weight constituents with bacterial aggregating activity from whole saliva and dental plaque.

Authors:  D I Hay; R J Gibbons; D M Spinell
Journal:  Caries Res       Date:  1971       Impact factor: 4.056

8.  Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli.

Authors:  I Orskov; A Ferencz; F Orskov
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

9.  Saliva-induced aggregation of oral streptococci.

Authors:  S Kashket; C G Donaldson
Journal:  J Bacteriol       Date:  1972-12       Impact factor: 3.490

10.  Fibroblast receptor for cell-substratum adhesion: studies on the interaction of baby hamster kidney cells with latex beads coated by cold insoluble globulin (plasma fibronectin).

Authors:  F Grinnell
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539

View more
  7 in total

1.  Secretion of type-1-fimbriae binding proteins from human neutrophil granulocytes.

Authors:  A Karlsson; C Dahlgren
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

2.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

Authors:  S F Kuan; K Rust; E Crouch
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells.

Authors:  H S Courtney; D L Hasty
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin.

Authors:  D K Paruchuri; H S Seifert; R S Ajioka; K A Karlsson; M So
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Binding of type 1-piliated Escherichia coli to vaginal mucus.

Authors:  M F Venegas; E L Navas; R A Gaffney; J L Duncan; B E Anderson; A J Schaeffer
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

Review 6.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

7.  A Novel Integrated Way for Deciphering the Glycan Code for the FimH Lectin.

Authors:  Tetiana Dumych; Clarisse Bridot; Sébastien G Gouin; Marc F Lensink; Solomiya Paryzhak; Sabine Szunerits; Ralf Blossey; Rostyslav Bilyy; Julie Bouckaert; Eva-Maria Krammer
Journal:  Molecules       Date:  2018-10-28       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.